Optima Pharma
Optima Pharma, headquartered in Germany, is a leading player in the pharmaceutical industry, specialising in the development and manufacturing of high-quality injectable solutions. Founded in 2004, the company has established a strong presence in Europe and beyond, focusing on innovative products that cater to the needs of healthcare providers and patients alike. With a commitment to excellence, Optima Pharma offers a range of core services, including contract manufacturing and customised solutions for sterile products. Their state-of-the-art facilities and adherence to stringent quality standards set them apart in a competitive market. Recognised for their expertise, Optima Pharma has achieved significant milestones, positioning themselves as a trusted partner in the pharmaceutical landscape.
DitchCarbon Score
How does Optima Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Salt and Mineral Mining industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Optima Pharma's score of 6 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Optima Pharma's reported carbon emissions
In 2014, Optima Pharma reported total carbon emissions of approximately 383,000 kg CO2e, comprising 22,980 kg CO2e from Scope 1, 15,320 kg CO2e from Scope 2, and a significant 344,700 kg CO2e from Scope 3 emissions. The company has made substantial commitments to reduce its carbon footprint, having already achieved a 40% reduction in operational emissions since 2009 through sourcing green electricity and implementing additional measures. Looking ahead, Optima Pharma aims to further reduce its Scope 1 and 2 emissions by at least 50% by 2030, compared to 2021 levels, and is targeting net zero emissions by 2050. This commitment includes an additional 25% reduction in emissions by 2030, focusing on enhancing energy and resource efficiency and promoting sustainable mobility across its operations. These initiatives reflect Optima Pharma's dedication to addressing climate change and minimising its environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2014 | |
|---|---|
| Scope 1 | 22,980 |
| Scope 2 | 15,320 |
| Scope 3 | 344,700 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Optima Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
